A 6-month, randomized, double-blind, parallel-group, controlled, multi-center study to evaluate the incidence of gastric ulcers with PN 400 (esomeprazole/Naproxen) versus diclofenac/misoprostol in subjects who are at high risk for developing NSAID [non steroidal anti-inflammatory drugs]-associated ulcers.
Phase of Trial: Phase III
Latest Information Update: 27 Aug 2010
At a glance
- Drugs Diclofenac/misoprostol; Esomeprazole/naproxen
- Indications Ankylosing spondylitis; NSAID-induced ulcer; Osteoarthritis; Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors POZEN
- 28 May 2008 Status change from recruiting to discontinued, according to clinicaltrials.gov.
- 31 Jan 2008 New trial record.